Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Inhaled colistin for the treatment of multidrug-resistant gram-negative bacilli lower respiratory tract infections: a retrospective chart review

  • At: 2016 FIP Congress in Buenos Aires (Argentina)
  • Type: Poster
  • By: LIANG, Shin-Yi (E-Da Hospital, Pharmacy, Kaohsiung, China Taiwan)
  • Co-author(s): Shin-Yi Linag:|Li-Ching Chien:|Yi-Ping Hsiang:
  • Abstract:

    In emerging multidrug-resistant (MDR) Acinetobacter and Pseudomonas pulmonary infections, colistin has been the last line of effective antibiotics. Data support inhaled colistin as a new effective adjuvant treatment for MDR gram-negative bacilli ventilator associated pneumonia. Few studies evaluated the efficacy of inhaled colistin only with..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses